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Abstract.  A mutant cell line, derived from the mouse 
embryonal carcinoma cell line F9, is defective in cell- 
cell adhesion (compaction) and in cell-substrate adhe- 
sion. We have previously shown that neither uvomoru- 
lin (E-cadherin) nor integrins are responsible for the 
mutant phenotype (Calogero, A., M.  Samuels, T.  Dar- 
land, S. A. Edwards, R. Kemler, and E.  D.  Adamson. 
1991. Dev. Biol.  146:499-508).  Several  cytoskeleton 
proteins were assayed and only vinculin was found to 
be absent in mutant (5.51) cells. A chicken vinculin 
expression vector was transfected into the 5.51 cells 
together with a neomycin-resistance vector. Clones 
that were adherent to the substrate were selected in 
medium containing G418.  Two clones, 5.51Vin3 and 
Vin4, were analyzed by Nomarski differential inter- 
ference contrast and laser confocal microscopy as well 
as by biochemical and molecular biological techniques. 
Both clones adhered well to substrates and both exhib- 
ited F-actin stress fibers  with vinculin localized at 
stress fiber tips in focal contacts. This was in marked 
contrast to 5.51 parental cells, which had no stress 
fibers and no vinculin. The mutant and complemented 
F9 cell lines will be useful models for examining the 
complex interactions between cytoskeletal and cell ad- 
hesion proteins. 
ARLIER studies have established that the cytoplasmic 
domains of two transmembrane  glycoproteins, uvo- 
morulin (Nagafuchi and Takeichi, 1988) and/31 inte- 
grins (Hayashl et al., 1990; Marcantonio et al., 1990; Reszka 
et al., 1992) are essential for transmembrane linkage to the 
cytoskeleton and for cell adhesion. The former glycoprotein 
links cells together in tight aggregates and epithelial sheets, 
the latter attaches cells to the extraceUular matrix.  Neither 
activity can be maintained without a set of interlinked cyto- 
plasmic accessory  proteins  that are actively disassembled 
and reassembled onto the F-actin cytoskeleton.  Uvomoru- 
lin, catenins or, B, 7 (Kemler and Ozawa, 1989) and plako- 
globin (Cowin et al.,  1986) are components unique to the 
zonulae  adherens junctions between cells.  Others  such as 
a-actinin, tenuin, vinculin, zyxin, are common to both zon- 
ulae adherens and cell-substrate plaques. Yet other proteins 
are  unique  to  cell-substrate  locations;  certain  integrins, 
fimbrin, paxillin, talin, and tensin for example (Geiger and 
Ginsberg,  1991). 
We have previously described an F9 mutant cell line that 
is defective  in both cell-cell and cell-matrix adhesion (Grover 
Address correspondence to Dr. Adamson  at La Jolla Cancer Research Foun- 
dation,  10901  North Torrey Pines Road, La Jolla, CA 92037. 
M.  Sarnuels and Dr.  Ezzell contributed equally to this work. 
et al., 1987). The F9 att-5.51 line (called 5.51 hereafter) was 
produced by ethylmethanesulfonate mutagenesis, a process 
that can lead to a single base change in the genome (Ingle 
and Drinkwater, 1989) or to a wide range of  mutational types 
(Wood and Moses,  1989). Unlike wild-type F9 cells,  5.51 
cells cannot differentiate into an epithelial layer after treat- 
ment of cell aggregates with retinoic acid (5 nM RA), prob- 
ably because they cannot aggregate into tight cell masses. In- 
stead, they grow in suspension even in tissue culture dishes 
as floating, loose and uncompacted  aggregates. RA treat- 
ment of 5.51 cells results in only parietal-type  endoderm 
differentiation; epithelial layers of polarized visceral endo- 
derm cells are not seen (Grover et al.,  1987). 
We have attempted to define the mechanism underlying  the 
inability of the mutant cell line to undergo compaction by 
studying  the  expression  of  uvomorulin  in  5.51 cells. 
Uvomorulin was expressed at 30-50%  wild-type F9 levels 
in mutant 5.51 cells while the mRNA was barely detectable 
because  it was highly  unstable  (Adamson et al.,  1990). 
When uvomorulin was overexpressed in 5.51 cells, the cells 
aggregated better  but did not form an epithelial  layer of 
visceral endoderm cells and did not adhere to a substrate 
(Calogero et al.,  1991). In short,  the replacement of uvo- 
morulin did not complement the cell-cell mutant phenotype. 
We examine here the expression of several cytoskeletal 
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differences can be found in the expression of several proteins 
in mutant cells, vinculin is completely missing. We present 
evidence that this is the fundamental cause of the aberrant 
cell-cell and cell-matrix interactions displayed by 5.51 cells. 
Vinculin (Mr 117 kD) localizes at focal contacts (Geiger, 
1979;  Burridge and Feramisco, 1980;  Geiger et al.,  1980) 
and intercellular adherens junctions (Geiger et al.,  1981; 
Geiger and Ginsberg, 1991). Therefore, any cell that makes 
contact with other cells or with substratum, expresses vincu- 
lin. By inference, this includes all anchorage-dependent cul- 
tured cells (Otto,  1990).  Vinculin is evolutionarily highly 
conserved  among  nematodes  (Barstead  and  Waterston, 
1989),  birds (Price et al.,  1989),  and man (Weller et al., 
1990).  The structural and functional domains of vinculin 
have been summarized recently (Westmeyer et al.,  1990; 
Critchley et al., 1991). There is a single gene, but a differ- 
ence in splicing gives rise to the 150-kD metavinculin vari- 
ant in muscle cells (Koteliansky et al., 1992).  We describe 
here the results of the transfection of an expression vector 
coding for chicken vinculin into the mouse 5.51 cell line and 
the isolation of several clones that express different levels of 
vinculin protein.  The conclusions are: (a) that the mutant 
phenotype is largely corrected,  because both compaction 
and substrate adhesion are significantly improved; (b) actin 
stress fibers lacking in the mutant line are restored in the 
transfected lines; (c) cell surface topography and motility are 
restored in clones that express moderate amounts of exoge- 
nous vinculin protein but not in those that express very high 
levels.  Our results suggest that subtle and complex regula- 
tory interactions with other components in the cytoskeletal 
network are necessary for normal function. 
Materials and Methods 
Cell Culture 
Wild-type  F9 BIM cells were cultured as described earlier (Grover et al., 
1983).  The mutant F9 cell line was cultured in suspension in the same 
medium (Grover et ai.,  1987).  Transfected  cell lines are designated as 
5.51UM1 and 5.51Vin for clones expressing uvomorulin or vinculin, respec- 
tively. PI9 embryonal carcinoma cells are cultured similarly to F9 cells but 
in noncoated dishes (McBurney et al.,  1982). 
Antibodies Used in Immunoblotting 
and Immunoprecipitation 
Rabbit  antibodies  to  uvomorulin,  ~fodrin,  and  ankyrin  were  kindly 
provided by R.  Kemler (Max Planck Institut, Freiburg, Germany), E. 
Repnsky (Roswell Park Cancer Institute, Buffalo, NY) (Black et al., 1988), 
A.  Dutton (University of California, San Diego,  CA) and W. J.  Nelson 
(Stanford University, Stanford,  CA) (Nelson and Veshnock,  1986), respec- 
tively. Rabbit anti-taiin  antisera were from K. Burridge (University of North 
Carolina, Chapel Hill, NC) and M. C. Beckerle (University of Utah, Salt 
Lake  City,  UT).  Anti-o~-actinin was  from A.  Dutton and S.  J.  Singer 
(University of California, San Diego,  CA). Three anti-vinculin antibodies 
were used:  for immunoprecipitation, a polyclonai  rabbit antibody to por- 
cine smooth muscle vinculin from A. Dutton; for immunoblotting, mouse 
mAb V4505 (anti-chicken)  and V9131 (anti-human) vinculin from Sigma 
Chemical Co. (St. Louis, MO). Anti-filamin  has been described previously 
(Ezzell  et al.,  1988). 
Immunofluorescence and Confocal Microscopy 
F9 cells were cultured for 24 h (48 h for 5.51 mutant and 5.51Vin-clones 
3 and 4) on polylysine-coated  coverslips.  Coverslips  with attached cells 
were fixed for 8 rain in 4 % paraformaldehyde  in PBS and permeabilized 
for 2 rain in 0.2%  Triton X-100 in PBS. After rinsing,  the coverslips were 
incubated for I h in a blocking solution containin$ 3 % BSA (Sigma Chemi- 
cal Co.) and 1% normal donkey  serum (Jackson  Immunoresearch Labs, 
Inc., West Grove, PA). grdd-type F9 ceils were stained with mouse anti- 
human smooth muscle vinculin (diluted 1:50, Chemicon International, Inc., 
Temecula,  CA,  catalog number MABI624), and 5.51Vin-clones 3 and 4 
were  stained with mouse anti-chicken gizT~rd smooth muscle vinculin 
(diluted 1:10, Sigma Chemical Co., catalog number VIN-I1-5) for I h. Both 
antibodies were diluted in blocking solution. The coverslips were washed 
(four changes,  15 rain each), and incubated for 1 h in fluorescein (DTAF)- 
conjugated  F(ab')2 fragment of donkey  anti-mouse IgG (diluted  1:200 in 
blocking solution,  Jackson Immunoresearch Labs).  The coverslips  were 
washed overnight and then stained with rhodamino-phalloidin (diluted 
1:100, Molecular Probes,  Inc.,  Eugene,  OR) to visualize F-actin.  After 
washing  for 15 min, the coverslips  were mounted in a drop of 1 mg/ml 
p-phenylenediamine (Sigma  Chemical Co.) to reduce photobleaching in 
90% glycerol/PBS,  pH 8.5. All specimens were examined in a confocai mi- 
croscope (BioRad MRC 600 [BioRad Microsciences, Cambridge, MA]) at- 
tached to a Zeiss Axiovert 35 with a I00x Plan-Neofluar  objective.  Confo- 
cal images were collected and digitally stored using photon-counting  Biorad 
COMOS software. 
71me-lapse Iruleo  Microscopy 
For time-lapse video microscopy, F9 cells were cultured on 25 mm circular 
coverslips coated with gelatin (for wild-type and 5.51 V'm clones 3 and 4) 
or polylysine (for 5.51 cells). The cells were maintained in a Leiden cover- 
slip chamber (Medical Systems Corporation, Greenvale, NY) and examined 
in a Zeiss Axiovert 10 inverted microscope using a 100x Plan-Neoflnar ob- 
jective and Nomarski differential  interference contrast (DIC) I optics.  A 
Zeiss environmental  microscope chamber was used to maintain  the cell cul- 
tures at 37°C  and 5%  CO2. Video  images  obtained with a  Hamamatsu 
C2400 Newvicon camera were recorded onto a Sony LVR 5000 laserdisk 
recorder at 15-s intervals. 
Plasmids 
(a) For probing Northern blots, a 3-kb human vinculin cDNA, HV6, was 
used 0Veller et al.,  1990) after labeling by the random oligonucleotide 
method (Feinberg and Vogelstein,  1984). (b) An expression vector encod- 
ing full-length chicken cDNA was constructed from cVinl and cVin5 (Ben- 
dori et al., 1989). The promoter was the Simian Vh-'us-40  late promoter de- 
rived from pSVL. (c) A plasmid containing the 1.2-kb EcoRl fragment of 
the  mouse  vinculin cDNA  (Ben-Ze'ev  et  al.,  1990)  in  Bluescript KS 
(Stratagene Corp., San Diego, CA) was linearized with BamH1 and cRNA 
of 220 bp corresponding to nts 1435-1649  of vinculin (Price ct ai.,  1989) 
was synthesized from the T3 promoter according to the method of Melton 
et al. (1987). This was used in ribonuclease protection assays together with 
a probe that detects ribosomal protein mRNA, L32, used as a control for 
equal loading of RNAs, as described by Darland et al. (1991). The protected 
fragment of mouse vinculin RNA was 205 bp. 
Transfections 
Mutant F9 cells grow as loose aggregates  in suspension.  In contrast, we 
might expect to find adherent cells if vinculin expression rescued the inabil- 
ity to adhere.  Dishes (10 cm) containing 1-2 ×  106 suspended  5.51 ceils 
were treated with 18 t~g plasmid DNA as a mixture of 15/~g pSVL-cVIN 
(expressing  chicken vinculin cDNA) and 3/tg pSV2neo (for G418 resis- 
tance). The method described by Graham et ai. (1974) was followed and 
colonies resistant to 0.4 mg/ml G418 were selected in tissue culture dishes 
that were coated with gelatin.  Clones that could adhere to the substratum 
were selected as well as less-adherent  ceil clones. Two clones, 5.51Vin3 and 
4, are described in the most detail. 
RNA Extraction and Analysis 
RNA was extracted from cells as described by Chirgwin et al.  (1974). 
Northern analysis was performed on formnidehyde-denaturing  gels (Mania- 
tis et al.,  1982) with 20 ~g of total RNA, after transfer to Nytran mem- 
branes (Schleicher and Schuell, Inc., Keene, Nil). RNase protection assays 
were as described above with 50 ~,g total RNA. 
1. Abbreviations used in this paper: DIC, differential interference contrast. 
The Journal of Cell Biology, Volume 121, 1993  910 Figure I. Morphology of  wild-type F9 (,4) and 5.51 (B) cells examined with Nomarski differential interference contrast optics. The wild-type 
cell is well-spread and has filopodia (arrows) and lameUipodia (arrowheads). In contrast. 5.51 cells are rounded and have only filopodia 
(arrows). 5.51 cells also grow as loose strings or clusters of non-adherent cells. Bar, 10 #m for A, and 6 #m for B. 
Radiolabeling and Immunoprecipitation 
Radiolabeling and immunoprecipitation were performed as in Darland et 
al. (1991). In brief, cells were labeled for 1 or 2 h in methionine-free me- 
dium  containing  200  t~Ci/ml  [3SS]methionine  and  cysteine  (ICN  Im- 
munoBiolngicals, Lisle, IL, TranSlabel >1,000 Ci/mrnol). Cells were lysed 
in RIPA buffer (1% deoxycholate,  1% Nonidet 40, 0.1% SDS, 25 mM Tris 
pH  7.5, 0.15  M  NaC1,  with protease inhibitors: 1 mM PMSE 2/~g/ml 
leupeptin and 2 ~g/mi aprotinin) and aliquots containing equal amounts of 
radioactive proteins were subjected to immunoprecipitation. Fixed Staphy- 
lococcus aureus (Boehringer-Mannheim  Corp., Indianapolis,  IN) precipi- 
tated complexes were analyzed by SDS-PAGE on 7 or 5% polyacrylamide 
gels.  The radioactive proteins were detected by ttuorography. 
Immunoblotting 
Known numbers of cells (105 to 106 cells per lane) were lysed and heated 
in sample buffer (Laemmli,  1970).  SDS-PAGE analysis was followed by 
transfer to Immobilon membranes (Miilipore Corporation, Bedford,  MA). 
Rainbow Markers (Amersham Corporation, Arlington Heights,  IL) were 
used to indicate the migration of proteins. Incubation of membranes in 
1:200 to  1:500  dilutions of specific  antibodies followed  by peroxidase- 
labeled second antibodies at 1:500 was done according to the manufacturer's 
instructions (NOVEX,  Encinitas, CA). Peroxidase was detected by staining 
using hydrogen peroxide and diaminobenzidine. Immunoblots in Fig.  9 
were digitized by scanning with a Hewlett Packard  ScanJet Plus attached 
to an Apple Macintosh IIci computer.  A software program called Adobe 
Photoshop 2.0 (Adobe Systems, Mountain View, CA) was used to increase 
the contrast of  the image. The contrast-enhanced  digitized images were then 
photographed onto 35 mm Kodak TMAX 100 black and white negative film 
with a Lasergraphics LFR Plus film recorder. 
Results 
Mutant F9 (5.51) Cells Have Altered Morphology and 
F-Actin Organization 
While  wild-type  F9  cells  adhere  and  spread  on  gelatin- 
coated plastic,  5.51  cells float in the medium as loose ag- 
gregates (Grover et ai.,  1987). Wild-type F9 cells become 
flattened as they spread but remain in colonies on the sub- 
stratum.  Time-lapse video and laser confocal microscopy 
were used to examine the motile behavior and distribution 
of actin filaments  (F-actin) and vinculin in wild-type and 
5.51  cells.  Wild-type F9  cells adhere to  surfaces by first 
sending out long fingerlike filopodia. This is soon followed 
by protrusions of lamellipodia (Fig.  1 A).  5.51  cells have 
filopodia but no lamellipodia (Fig.  I  B). 
In wild-type ceils, F-actin is organized into stress fibers 
that terminate at focal contacts containing vinculin (Fig. 2, 
C and D). 5.51 cells do not have stress fibers and do not stain 
with vinculin antibodies (Fig. 2, E and F). Instead, F-actin 
is concentrated under the plasma membrane and in filopo- 
dia. Wild-type F9 cells observed 15 min after seeding have 
already begun to attach to a  gelatin-coated substrate  and 
while still rounded in shape are nevertheless able to organize 
vinculin into short nascent focal adhesion points (Fig. 2 A) 
even though actin stress fibers are not apparent (Fig. 2 B). 
These findings suggest that vinculin is required for attach- 
ment and spreading as well as for the formation of stress 
fibers. 
Vinculin Levels in F9 Cells: Biochemical and 
Molecular Biological Evidence 
Because vinculin staining is not evident in the mutant cells 
shown in Fig. 2 E, we extracted equal numbers of wild-type 
F9 and 5.51 cells to analyze their vinculin content by immu- 
noblotting. The results show that wild-type IX) and P19 EC 
cells contain very similar steady-state levels of vinculin (Fig. 
3,  lanes  1,  2,  and  5)  whereas  5.51  and  its  uvomorulin- 
expressing clone 1 (Calogero et al.,  1991) have no visible 
vinculin protein. 
Because vinculin could be unstable in 5.51 cells, it might 
be detectable with greater sensitivity if measured by meta- 
bolic labeling of newly synthesized protein. Equal amounts 
of radioactively-labeled lysate were analyzed with a  poly- 
clonal anti-vinculin to compare immunoprecipitates from 
wild-type and mutant cells (Fig. 4). Only wild-type F9 cells 
gave the expected ll7-kD band. There was no such labeled 
polypeptide in 5.51 cells or with nonimmune serum. Fig. 4 
A also shows the electrophoretic migration of uvomorulin in 
a similar aliquot of F9 lysate. In this case the F9 cells had 
been treated with tunicamycin and both glycosylated and un- 
derglycosylated  versions of uvomorulin are seen as a doublet 
Samuels et al.  Vinculin Expression in Mutant F9 Cells  911 Figure 2.  Colocalization of vinculin  (A, C, E) and F-actin (B, D, F) in wild-type F9 (A-D) and 5.51 (E and F). Cells were strained with 
a mouse monoclonal  antibody to human vinculin, and then stained with rhodamine-phalloidin  (see Materials and Methods).  Confocal im- 
ages are of the ventral surface in contact with the substrate  (for wild-type cells) and of the midsection of the cell (for 5.51). Wild-type 
F9 cells were observed  15 min (A and B) and 2 h (C and D) after seeding. After 2 h, F9 cells are fully spread and stress fibers are seen 
to terminate in vinculin-containing  focal contacts (arrows).  Even after 15 rain, vinculin  patches colocalize with F-actin at the cell periphery 
and in extending filopodia (arrows).  E and F show a 5.51 cell fixed and stained 2 h after addition to the substrate.  In this nonadberent 
cell type F-actin is concentrated at the cell periphery and in filopodia (arrows).  Aggregates of F-actin inside 5.51 cells were frequently 
observed.  Vinculin  staining with antibodies to human (E) or chicken (not shown) vinculin  was not detected in 5.51 cells. The round shape 
and F-actin organization in 5.51 cells resemble the adhering wild-type F9 cell (compare B with F). Bar, 5 #m for A, B, E, and F,, and 
10 #m for C and D. 
The Journal of Cell Biology. Volume 121, 1993  912 Figure 3.  Immunoblotting to detect vinculin in EC ceils.  Equal 
numbers of ceils were extracted  as described in the Materials  and 
Methods section.  Vinculin was assayed by a two-layer method em- 
ploying rabbit polyclonal anti-vinculin  and peroxidase labeled  sec- 
ond antibodies.  The stained  bands in the left-hand  panel indicate 
that equal levels of vinculin were detected in monolayer (mono) and 
in aggregated  (aggs) F9 EC cells and PI9 cells but none were ob- 
served in mutant 5.51 or its  uvomorulin transfected  clone,  5.51 
UM1  (denoted  C1). PI was nonlmmune serum negative  control. 
at about 120 kD. Vinculin moves at a slightly different migra- 
tion rate between the uvomorulin doublet. To maximize the 
ability to detect vinculin in 5.51 cells, threefold more radio- 
labeled 5.51 ceils compared to F9 wild-type were analyzed 
in Fig. 4 B. Even here, vinculin was not detected in 5.51 ly- 
Figure 5. Ribonuclease protection analysis of the relative levels of 
vinculin transcripts  in F9 cells stimulated with 20% serum and cy- 
cloheximide (10/xg/ml) for 1 h; 5.51 similarly  stimulated;  F9 cells 
after RA-stimulated  differentiation  for 4 d; unstimulated  F9 mono- 
layers,  and 3T3 ceils,  respectively.  L32 is the signal  given by ri- 
bosomal protein transcripts  and is used to control for RNA loading 
on the gel.  The relative  levels of vinculin mRNA in each sample 
are shown below. M, marker lane. 
Figure 4. Immunoprecipitation of methionine-labeled  F9 and 5.51 
mutant cells. (A) Equal amounts of radioactivity were compared as 
described in the Materials and Methods section. To demonstrate the 
presence  of uvomorulin  and  to  distinguish  between  UM  and 
vinculin, lane 1 shows uvomorulin protein synthesized  in F9 cells 
treated with tunieamycin to inhibit the glycosylation of  this protein. 
The triplet of proteins represents  UM precursor (125 kD), mature 
UM (120 kD), and the under-glycosylated form. The catenins (Cat) 
coprecipitate with UM as indicated  (Ozawa et al., 1989). Vinculin 
also migrates at ,'~120 kD and is seen only in lane 2, an extract of 
F9 ceils. There is no detectable vinculin in 5.51 cells (lane 4). (B) 
Here the amount of radioactive  5.51 lysate was threefold that of F9 
cells  but no immunoprecipitated vinculin could be seen.  Lanes 
marked PI are controls with a nonimmune rabbit serum. The mi- 
gration position of marker proteins is indicated  in kD. 
sates although a number of other nonspecific proteins were 
seen in anti-vinculin as well as nonimmune lanes.  We con- 
clude  that  vinculin  protein  is  absent  from the  mutant  F9 
ceils. 
The expression of vinculin mRNA was detected by North- 
ern blotting as a transcript of 6-7 kb in RNA extracts of F9 
and 3T3 mouse fibroblasts, but no signal above background 
levels could be seen in 5.51 cells (data not shown). To detect 
and quantify vinculin mRNA levels with greater sensitivity, 
a  ribonuclease  protection  assay  was  performed  using  a 
mouse cRNA that protects 205 bp of endogenous vinculin 
mRNA. Fig. 5 shows that the levels of vinculin mRNA in F9 
cells are lower than in fibroblasts. Note that stimulating ceils 
with  20%  serum  in  the  presence  of cycloheximide  (Ben- 
Ze'ev et al.,  1990) for 60 min,  or retinoic acid for several 
days, results in changes in the levels of vinculin mRNA. Un- 
like Northern blotting, a low level (approximately one-sixth 
of that found in F9) of vinculin mRNA was detected in mu- 
tant 5.51 cells using the ribonuclease protection assay. These 
levels  were  estimated  by  reference  to  the  level  of  L32 
ribosomal  protein  mRNA  which  was  assumed  to  be  in- 
variant. 
Transfection of Vinculin into 5.51 Cells Restores 
Adhesion, Morphology and Actin Organization 
Co-transfection of an expression vector encoding full-length 
chicken vinculin,  together with one that conveys neomycin 
Samuels et al. Vinculin  Expression in Mutant F9 Cells  913 l~gure 6.  Phase contrast  mi- 
crographs  compare the  gen- 
eral appearance  of a popula- 
tion of F9 wild-type (A) with 
transfeeted cells, 5.51Vin4 (B) 
and  5.51Vin3 (C)  grown  as 
monolayers.  5.51Vin3  cells 
attach  and  spread  compara- 
tively poorly 2 d after seeding 
(C), but in suspension culture 
aggregate  and  compact well 
(D). Bar in A, 50/am and ap- 
plies to all panels. 
resistance, allows the selection of stable cell lines carrying 
both genes. Selection in G418 gave a mixture of phenotypes, 
but we selected cells that either aggregated better or adhered 
better to the gelatin-coated substrate. The two properties ap- 
peared in parallel, thus supporting the idea that vinculin may 
be the major defect in the mutant cells.  Two main clones, 
5.51Vin3  and 5.51Vin4, were selected and subcloned. Clone 
3 was less adhesive than clone 4 in both rate of adhesion and 
flattened appearance in a monolayer (Fig. 6  C) but formed 
moderately tight aggregates in suspension cultures  (Fig.  6 
Figure 7. Morphology of 5.51Vin3 (.4) and 5.51Vin4 (B) cells examined with Nomarski difference interference contrast optics. Both clones 
are attached to the substrate and have filopodia (arrows) and larnellipodia (arrowheads). ~n3 is not as well spread as Vin4 and wild-type 
cells (see Fig.  1). Bar, 10/zm for A and B. 
The Journal of Cell Biology, Volume 121, 1993  914 Figure 8. Colocalization of vinculin (A, C) and F-actin (B, D) in 5.51Vin3 (A, B) and 5.51Vin4 (C, D) cells. Cells were stained with 
a mouse mAb to chicken vinculin, and then stained with rhodamine-phailoidin. Confocai images are of the ventral plasma membrane 
in contact with the substrate. Both clone 3 and 4 cells have aetin stress fibers that terminate in chicken vinculin-containing focal contacts 
(arrows). The abundance of stress fibers and vinculin staining in the 5.51Vin3 cell correlates with the increased expression of chicken 
vinculin (see Results). Bar, 10/~m for A-D. 
D). Clone 4 monolayers adhered well to plastic and spread 
sufficiently to resemble wild-type F9 cells (Fig. 6, compare 
A with B). 
5.51Vin clones 3 and 4 cells were observed with Nomarski 
Die optics in order to observe spreading and membrane mo- 
bility  (Fig.  7).  5.51Vin3  cells  did  not  spread  as  well  as 
5.51Vin4  and wild-type cells (see Fig.  1 A), but contrasted 
clearly with the rounded shape and absence of lameUipodia 
in the 5.51  parental line (compare Fig.  1 B with Fig.  7). 
We demonstrated next that the transfected cells not only 
expressed vinculin but also that they were able to place vin- 
culin at the ends of actin stress fibers which were now re- 
stored.  Fig.  8  shows that our two transfected 5.51  clones 
stained for chicken vinculin in a manner closely resembling 
that seen in wild-type F9 cells (see Fig. 2 C and D). Clone 
Vin3 had more actin stress fibers than clone 5.51Vin4,  and 
more vinculin associated with the ends of the stress fibers 
(compare Fig. 8, B with D). The vinculin in 5.51Vin4 local- 
ized in  focal contacts and clustered in  small patches dis- 
tributed over much of the cell surface. As shown in Fig. 8, 
a mouse mAb to chicken vinculin stained both 5.51Vin 3 and 
4 cells. The anti-human vinculin antibody used to stain the 
wild-type mouse F9 cells (see Fig. 2) did not stain these cells 
(data not shown) proving that the vinculin associated with fo- 
cal contacts in the transfected 5.51 cells is chicken vinculin 
and not endogenous mouse vinculin. These results demon- 
strate that chicken vinculin is being expressed in the trans- 
fected clones and suggest that this in turn is eifecting the as- 
sembly  of  F-actin  and  the  restoration  of a  normal  F9 
cytoarchitecture. 
Biochemical Evidence for the Expression of Chicken 
Vinculin in Transfected 5.51 Clones 
Immunoblotting with the polyclonal antibody to vinculin re- 
vealed that the two vinculin-transfected clones do indeed ex- 
press higher levels of vinculin than even wild-type F9 cells 
(Fig. 9, left). We used a 10-fold range of cell lysates to com- 
pare the levels. At this point, we also tested a  mixture of 
mouse mAb to human and chicken vinculin in order to try 
to increase the sensitivity of  detection in cells that contained 
both antigens. It is clear that the differential recognition of 
Samuels et al. Vinculin  Expression in Mutant F9 Ceils  915 Figure 9. Immunoblotting to compare the levels of expression of vinculin in transfected clones. Lysates of wild-type (a), 5.51 (b), 5.51UMI 
(c), 5.51Vin3 (d), 5.51Vin4 (e) cells were analyzed as described in the Materials and Methods section. Vineulin was detected on blots 
with the polyclonal antibody used in immunopreeipitation studies (left) and with a mixture of mouse mAb to human and chicken vinculin 
(r/ght). The second layer peroxidase-labeled antibodies were detected with diaminobenzidine and hydrogen peroxide. The number of cells 
assayed is shown above each lane:  Ix ffi lO  s, 5x ffi 5  ×  lO  s, 10x =  106 cells. 
antigens by antibodies in different techniques can give rise 
to different signal strength (Fig. 9, righO. We may be un- 
derestimating the expression of vinculin in wild-type cells 
(compare lanes a in Fig. 9), but even with this increased sen- 
sitivity, there is no vinculin protein in either the 5.51  cells 
or the uvomorulin-transfected clones (Fig. 9, b and c). We 
have not assayed the floating transfected cells for vinculin 
expression. 
Because the rabbit polyclonal antibody recognizes both 
mouse and chicken vinculin albeit with different sensitivi- 
ties, we used it to examine and compare vinculin biosynthe- 
sis in metabolically-labeled ceils. Fig.  I0 (upper left) con- 
firmed that vinculin synthesis was not detectable in 5.51 cells 
in contrast to F9 cells. 5.5 IVin3 synthesized chicken vinculin 
at extremely high rates while in 5.51Vin4  cells the rate was 
similar  to  F9  wild-type  cells.  Because  all  the  vinculin- 
transfected clones gave more compact aggregates in suspen- 
sion cultures, we were interested in seeing if uvomorulin 
synthesis might have been increased by the expression of ex- 
tra  vinculin.  We  routinely observed unchanged  levels of 
uvomorulin synthesis  in  vinculin-transfected and parental 
5.51 cells: 30-50% of the level in wild-type F9 ceils (Fig. 
10, upper right; see also Adamson et al.,  1990).  We have 
never observed the induction of vinculin synthesis by the ex- 
pression of exogenous uvomorulin in 5.51  ceils. 
These and other clones were assayed for their steady-state 
levels of mouse vinculin mRNA by ribonuclease protection 
assay.  Using the mouse cRNA probe (this probe could not 
detect chicken transcripts), we could detect little difference 
in the levels of transcripts between 5.51 and any of the trans- 
fected 5.51  clones (data not shown). Therefore, the expres- 
sion of an exogenous chicken vinculin gene did not affect the 
low  levels of endogenous mouse vineulin mRNA  in 5.51 
cells. 
Other Cytoskeletal Protein Levels in F9 Cells 
Because vinculin is known to interact with talin and with 
~-actinin, these and several other cytoskeletal proteins were 
analyzed in immunoprecipitation assays and in immunoblot- 
ring. We made the assumption that the solubility of cytoskel- 
etal proteins of each cell type remained the same and hence 
that our extraction procedure was equally effective in F9 and 
mutant cells. Little difference was observed in the biosyn- 
thetic rates (Fig.  10, bottom) of the cytoskeletal proteins fo- 
drin (cx-spectrin), ankyrin (not shown) and filamin in 5.51, 
transfected 5.51 or wild-type cells. The rates of synthesis of 
filamin and fodrin were somewhat variable, but the differ- 
ences between F9 mutant and transfected cell lines were not 
significant. 
The steady-state levels of cytoskeletal proteins were also 
compared by immunoblotting. Fig.  11 shows that ~-actinin 
was  quite  similar  in  all  clones  while  filamin  and  fodrin 
steady-state levels were somewhat variable. Similar results 
were obtained for talin and ankyrin (not shown). However, 
there seemed to be a much lower level of  filamin in 5.51 cells, 
while  transfected clones  derived from 5.51  all  expressed 
higher levels of filarnin. We think that it is unlikely that the 
excess expression of either uvomorulin or vinculin could 
have caused this  increase and  so again  we conclude that 
clonal differences account for this result. In summary, there 
are  no  large  consistent  differences  in  the  expression  of 
cytoskeletal proteins among the five cell lines examined. 
Discussion 
The Mutant Phenotype Is Complemented by the 
Expression of Vinculin 
The defect in adhesion and actin organization in 5.51  cells 
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culin in trandect~ clones. Met- 
abolically-labeled  cells  were 
examined by immunoprecipi- 
tation  using  the  rabbit poly- 
clonal antibody that recognizes 
both mouse and chicken vin- 
culin. Analyses of the expres- 
sion  of vinculin  (upper  le~) 
were made before the immu- 
noprecipitation of  uvomorulin 
from the same lysates (upper 
right).  Fodrin (lower left) and 
filamin (lower right)  antibod- 
ies were applied  sequentially 
to an identical set of samples 
a through e, described in Fig. 
9.  All samples except c con- 
tained equal amounts of total 
radioactive  protein; c contained 
half the amount. The position 
of the  markers  is  shown  as 
kD on the left.  PI is nonim- 
mime  serum.  See  Materials 
and  Methods  for  details  of 
scanning and imaging. 
is corrected by the expression of the transfected chicken vin- 
culin gene. This is evidenced by the nearly normal rate and 
extent of substrate adhesion in two clones expressing chicken 
vinculin, especially in 5.51Vin4. In addition, cell-cell adhe- 
sion was improved. The introduction of moderate levels of 
vinculin into 5.51  cells (as in 5.51Vin4)  allowed the mutant 
cells to adhere to each other and to the dish surface. We con- 
clude that the major defect in the mutant cells is the loss of 
vinculin protein expression.  A  similar approach has been 
used by Barstead and Waterson (1989) to show that vinculin 
is  essential  for  muscle  development  and  function.  They 
identified a population of nematodes that are paralyzed, fail 
to organize normal muscle structure, and have reduced levels 
of vinculin. This lethal mutation was corrected by injection 
of a cloned wild-type copy of the vinculin gene. On the other 
hand, microinjection of a mAb to chicken vinculin disrupted 
stress  fibers and  led  to  loss  of focal contacts  in  chicken 
fibroblasts (Westmeyer et al., 1990). These observations are 
consistent with the hypothesis that vinculin is one of a num- 
ber of interacting proteins which link F-actin to the cytoplas- 
mic face of transmembrane glyeoproteins involved in cell 
adhesion. 
Samuels et al. Vinculin Expression in Mutant F9 Cells  917 Figure 11. Steady-state levels of other cytoskeletal proteins in wild-type, mutant and rescued ceils. (Left) Immunoblotting of c~-actinin in 
the five samples (a-e) described in Fig. 9. (Middle) A similar analysis of filamin in an equal number of cells (5 ×  105)  in identical lysates; 
(right) analysis of the steady-state levels of fodrin. 
Vinculin Expressed in Mutant Cells Is Correctly 
Localized and Restores the Actin Organization 
We argue that the induced expression of vinculin in 5.51 
Vin3 and 5.51Vin4 is causal in restoring the ability of  the mu- 
tant  cell  line  to  adhere to  substrates  and  to  form aedn- 
containing stress fibers (Fig. 8). Most of the over-expressed 
vinculin in 5.51Vin clones is located at the peripheral ends 
of actin stress fibers although some vinculin is also seen dis- 
persed throughout the cytoplasm and this is not normally 
seen in wild-type F9 cells (Fig. 2). As observed by others 
(Pfeiffer and Vogl, 1991; Horvath et al., 1992), vinculin ap- 
pears to be present in ceils in a pattern similar to actin but 
at the peripheral ends of actin stress fibers. The presence of 
stress fibers is clearly correlated with the shape of the cell 
and  to  its  ability  to  adhere  to  substrates  via  vinculin- 
containing cell matrix junctions. 
The Complementation of  Mutant Cells Is Imperfect 
At least two explanations might account for the slightly in- 
complete  complementation  of the  mutant  phenotype  by 
chicken vinculin to that exhibited by F9 parental cells. One 
is that chicken vinculin is sufficiently different to be unable 
to replace the mouse-type protein. This is unlikely, however, 
because there is 95 % similarity between chick and human 
vinculin (Weller et al., 1990). This question can be studied 
when a mouse vinculin vector becomes available. The sec- 
ond possibility is that exactly the right amount of vinculin 
is needed. This hypothesis is supported by our observation 
that 5.51Vin3 which expresses very high levels of vinculin is 
less able to adhere than 5.51Vin4  which expresses moder- 
ately high levels (Fig. 9). The presence of excess vinculin as 
in  5.51Vin3  cells  could  inhibit  cell  spreading  by  over- 
stabilization of stress fibers and by affecting the disassembly 
and reorganization of actin filaments. However, we have not 
yet detected a transfected 5.51 clone that adheres and spreads 
perfectly on the substratum so we are unable to test the hy- 
pothesis satisfactorily. The work of Fernandez et al. (1992a 
and b) strongly suggests that the level of vinculin expressed 
in a cell can alter cell behavior, because the over-expression 
of  vinculin in BALB/c3T3 cells by as little as 20% drastically 
reduces their motility (Fernandez et al., 1992a). Further, the 
restoration of  vinculin levels in several transformed cell lines 
that express little or no vinculin results in an increase in sub- 
strate adhesiveness and in suppressed tumorigenicity (Fer- 
nandez et al.,  1992b). 
Although we could detect no consistent differences in the 
levels of several cytoskeletal proteins in 5.5 l-derived clones, 
only filamin might be expressed at lower levels in 5.51 cells 
compared to F9 cells and we have previously documented 
that uvomorulin is present at 30-50% of wild-type F9 cells 
(Adamson et al., 1990). It is therefore possible that there are 
differences in the incorporation of these proteins into the 
cytoskeleton and that the mutant phenotype is exacerbated 
by lower levels of filamin and uvomornlin. Current studies 
also suggest that the transfected cells are not able to complete 
the process of epithelium formation after the addition  of 
retinoic acid to induce differentiation. The cells are not resis- 
tant to retinoic acid, however, because they do differentiate 
into parietal endoderm, a nonepithelial cell type. It should 
be noted that the ability of the mutant cells to proliferate is 
completely normal even in the absence of vinculin. 
We believe that the major defect in 5.51 cells is in the vin- 
culin gene or in a vinculin regulatory gene. We have never 
been able to select an F9 nonadhesive clone without muta- 
genesis. Therefore, this defect is not merely a characteristic 
of a  clonal variation.  Restriction enzyme analysis suggest 
that the structure of the vinculin gene in 5.51 cells is not de- 
tectably different from that in parental F9 cells and therefore, 
either a relatively subtle mutation has occurred or a regula- 
tory gene is aberrant in the mutant cells. 
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The work of DePasquale and Izzard (1987, 1991) shows that 
talin is first located at the tips of the focal contact precursors 
and then accumulates in the adhesion plaque after the focal 
contact  forms  and  before  vinculin  is  seen  there.  The 
filopodia-like protrusions in 5.51 cells may be focal contact 
precursors because, based on the above findings, vinculin is 
not required for their assembly. In 5.51 cells, talin may be 
at the tips of the filopodia but focal contacts and actin con- 
nections cannot be made because vinculin is absent. 
The difficulty of proper assembly of the cytoskeleton is 
reinforced by our growing knowledge of the level of com- 
plexity of interactions between the  cytoskeletal proteins. 
Adhesion of cells to a substrate occurs through a chain of in- 
teractions from/~-integrins to ct-actinin and actin (Burridge 
et al.,  1988;  Geiger and Ginsberg,  1991; Critchley et al., 
1991; Turner and Burridge, 1991; Hynes, 1992).  However, 
although vinculin binds avidly to talin (Jones et al., 1989), 
vinculin lacking the talin binding site retains the ability to 
associate with focal contacts (Bendori et al., 1989). This in- 
teraction could occur through a binding site on vinculin, pos- 
sibly the paxillin binding site, which is located toward the 
COOH-terminus of the molecule (Turner et al., 1990).  Vin- 
culin can also self-associate (Molony and Burridge, 1985). 
Furthermore, vinculin binds to t~-actinin and through the lat- 
ter protein to actin. Interestingly, a,-actinin appears to bind 
directly to B1 integrin (Otey et al., 1990) even though it ap- 
pears to be located some distance from the membrane (Chen 
and Singer,  1982). 
We have shown here that vinculin is necessary for cell at- 
tachment, however,  the spreading of cells after attachment 
is more complex and may not be a function of vinculin (al- 
though see Lehtonen et al.,  1983).  BALB/c-3T3cells re- 
plated from suspension cultures attach and spread exten- 
sively even in serum-free cultures when only basal levels of 
vinculin are present and vinculin is not detectable in the focal 
contacts. When serum is present however, vinculin expres- 
sion is  induced and large  vinculin-positive plaques  form 
(Ben-Ze'ev et al., 1990). Ben-Ze'ev et al. (1990) suggest that 
there may be two kinds of focal contacts, with vinculin pres- 
ent in only one type. It is possible that our complemented 
clones, 5.51Vin3 and 4, are unable to organize the nonvincu- 
lin focal adhesions. This may explain the incomplete appear- 
ance of adhesion. Vinculin expression is transcriptionally in- 
duced by serum growth factors and increases in vinculin 
synthesis requires both initial attachment to the substratum 
and serum factors. An autoregulatory mechanism linking 
the  mode  of vinculin organization to  the  growth  factor- 
mediated control of vinculin gene expression has been sug- 
gested (Ben-Ze'ev  et al.,  1990).  Such a control mechanism 
has been demonstrated for tubulin regulation (Ben-Ze'ev  et 
al., 1979; Cleveland et al., 1981) and may operate for other 
cytoskeletal  elements.  Nevertheless,  serum  induction  of 
cells in suspension culture is not effective in up-regulating 
vinculin  expression;  cell  attachment  to  the  substrate  is 
necessary for induction. The mechanism of this requirement 
remains obscure. Our observations suggest that cell attach- 
ment is a catalyst for further adhesion and spreading. Al- 
though 5.51Vin clones attach at different speeds after tryp- 
sinization (perhaps depending on their level of expression of 
vinculin), all clones eventually appear similar in morphol- 
ogy, adhesion and strength of attachment. 
The Role of Vinculin in Cell-Cell Compaction and 
Adherens Junctions 
Wild-type F9 cells express uvomorulin at high levels (Pey- 
rieras  et  al.,  1985).  Immunoprecipitation of uvomorulin 
coprecipitates ct,/~, and 3' catenins (Vestweber and Kernler, 
1984;  Ozawa  et  al.,  1989).  Interestingly,  ~catenin  has 
~30%  similarity to vinculin (Nagafuchi et al.,  1991; Her- 
renknecht et all.,  1991). The cytoplasmic portion of uvo- 
morulin is necessary to associate with c~-catenin (Nagafuchi 
and Takeichi, 1989; Ozawa et al., 1990).  The hypothesis is 
that uvomorulin forms a molecular complex with the actin- 
based cytoskeleton via the catenins and other proteins at the 
cytoplasmic domain. This association is essential for uvo- 
morulin to act as a cell-cell adhesion receptor. The adherens 
junctions have tightly-associated actin filaments (Geiger et 
al., 1980; Tsukita et al., 1989; Tsukita et al., 1992) and al- 
though coprecipitation ofvineulin does not occur in the pres- 
ence of antibodies to actin, its distribution is markedly simi- 
lar to actin patterns (Pfeiffer and Vogl, 1991; Horvath et al., 
1992). It is possible that these associations are the trigger for 
the homotypic association between uvomorulin on adjacent 
cells that leads to cell-cell compaction and the formation of 
adherens junctions. 
It has been observed that the shape of a cell, the nature of 
the substratum and the degree of contact with adjacent cells 
(Shirinsky et al., 1991) directly regulate the synthesis of vin- 
culin in cultured fibroblasts (Ungar et al., 1986). In addition, 
vinculin is an immediate early gene, responding rapidly to 
the addition of serum growth factors by up-regulating its 
transcription (Ben-Ze'ev  et al.,  1990;  Bellas et al.,  1991). 
Fibronectin (Dean et al., 1990), ~l-integrin, ot-tropomyosin 
and -y and fl-actin (Ryseck et al.,  1989)  are also early re- 
sponse genes. It is clear, therefore, that cell interaction, cell 
shape, molecular interactions at the cytoplasmic domains of 
adherens junctions  and  early  signal  transduction  are  all 
cross-regulated and correlated with long-term signals and 
cell behavior. The mutant F9 cell line will be an important 
model for studies of the molecular interactions between the 
components involved in adhesion and the consequences of 
perturbations made to single components. 
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